As we have reported frequently here at Health Impact News, sales of drugs to lower cholesterol are the top selling drugs of all time. It is a $100 billion a year industry. The cholesterol-lowering drug Lipitor is the best-selling drug of all time, grossing over $140 billion, with no serious close competitors in the history of pharmaceutical drugs. One out of every four Americans over the age of 50 is taking a statin drug to lower their cholesterol. However, these block buster drugs have run through their patent life, and now generics dominate the market. So Big Pharma is looking at new ways to patent new drugs to lower your cholesterol. The latest? A vaccine is being developed to lower your cholesterol. In recent years, class action lawsuits have been stacking up against statin drug manufacturers due to the terrible side effects, including diabetes. Is this another reason for turning to vaccines to "cure" cholesterol? In this country, lawsuits against vaccines are prohibited while civil suits against prescription or over-the-counter drugs are allowed.
In what appears to be a coordinated attack against the rising popularity of coconut oil, the American Heart Association (AHA) has just published a "Presidential Advisory" on "Dietary Fats and Cardiovascular Disease" in which it condemned coconut oil, and recommended that people not consume it. The AHA's recommendation clearly contradicts research that exists on not only coconut oil but saturated fats in general, which debunks the old lipid theory of heart disease that saturated fat and cholesterol cause heart disease. Yet, the mainstream corporate-funded media published its recommendations with no critical analysis or journalistic investigations into the AHA's claims. Are these attacks against coconut oil part of an effort by Big Pharma to protect its $100 billion a year cholesterol lowering statin drug industry?
The pharmaceutical empire strikes back. After the recent few years of increasing “statin deniers” getting an occasional mainstream media appearance, vested interest parties are coming up with studies to “prove” statins (cholesterol-lowering drugs) are safe. The problem is most folks on the fence, as most are, will be distracted by these studies no matter how biased and without merit they may be. Doctors who know the truth about statins are forced to pick any such statin safety study apart in response in order to straighten out doctors who prescribe statins based on pharmaceutical reps’ presentations and industry biased studies. One such doctor who is outspokenly critical of statin drugs, Scottish General Practitioner (GP) Malcom Kendrick, M.D., recently focused on a Lancet paper that intended to prove side effects from statin drugs were not only greatly exaggerated, but all in the patients' heads. According to the paper, patients were suffering from the “nocebo effect,” due to all the rising information regarding statin side effect symptoms publicly reported. In addition to his analysis of the study and comparisons to other studies, Dr. Kendrick offers his personal and professional experiences of taking patients off statins and watching them recover from torn or ravaged muscles and early onset dementia, among other side effects. Dr. Kendrick’s father, whose side effects had him wheel chair bound until his doctor-son convinced him to quit taking statins is an example he offered. No nocebo effects had them in such terrible shape that was relieved when they got off statins.
A 2017 meta-analysis of 29 studies has concluded that consuming dietary dairy fat has no negative effects on all cause mortality or mortality from cardiovascular disease (CVD) and coronary heart disease (CHD). This includes dairy fats of all types. One of the researchers, Ian Givens of England’s Reading University, commented on the record: “There’s been a lot of publicity over the last 5 to 10 years about how saturated fats increase the risk of cardiovascular disease and a belief has grown up that they must increase the risk, but they don’t.” Actually, dairy and other animal sourced saturated fats have been wrongly condemned as a contributor to obesity and higher cardiovascular risk since Ancel Keys' notorious seven countries study over 50 years ago, which spawned the “lipid theory” of heart disease and obesity.
LCHF stands for a low carbohydrate and high fat diet. Not only does this diet protocol threaten the official nutritional dietary dogma of high carbohydrates and low fats (including NO saturated fats, as per USDA nutritional guidelines), promoting LCHF also threatens the sugar and processed food industries where it hurts, financially. So as with all things proven unscientific that support current industrial endeavors, promoting accurate current science to upset all endeavors associated with misinformation warrants attacks on the messengers while suppressing their scientific evidence. The science behind LCHF has been known at least since the 1920's when the ketogenic diet was developed at Johns Hopkins Hospital as a cure for childhood epilepsy, being used when drugs failed. Dr. Tim Noakes, MD, a South African scientist and emeritus professor at University of Cape Town’s Division of Exercise Science and Sports Medicine was attacked by nutrition officials almost three years ago in 2014. After three years of public court room hearings, with all its legal expenses and stressful distractions, he was recently acquitted.
The saturated fat lie is officially exposed now that the British Journal of Sports Medicine, a division of the BMJ (British Medical Journal) emphatically declared: “Saturated fat does not clog the arteries: coronary heart disease is a chronic inflammatory condition, the risk of which can be effectively reduced from healthy lifestyle interventions.” The beginning of this very recent BMJ letter, 31 March 2017, reviewing several mega-studies, states early in their editorial: “Despite popular belief among doctors and the public, the conceptual model of dietary saturated fat clogging a pipe is just plain wrong.” Wrong, unequivocally and indisputably, not maybe or could be or further studies needed, but completely wrong. It’s over. And the root cause of arterial inflammation is cited with dietary recommendations that lean toward the Mediterranean Diet.
The health ramifications of virgin coconut oil keep surfacing from international studies without much coverage from mainstream media health or food sections. Fortunately, Health Impact News and their CoconutOil.com website is the leading authority today on the health benefits of coconut oil, keeping you up-to-date on all the published research about coconut oil you will never read in the mainstream corporate media. There has been a lot of text and talk about the wonders of coconut oil’s medium chain fatty acids and how they benefit the brain by producing ketones for brain cells’ functional nutrition. Ketones can even reverse Alzheimer’s disease. Of course, the pharmaceutical industry and their support of the mainstream media would like to keep that information from being known. There are even folks losing weight with high-fat ketogenic dieting, which includes the saturated fat coconut oil and other whole unadulterated healthy fats, to debunk the unscientific dogma of saturated fats as responsible for obesity. Many studies have demonstrated coconut oil’s antifungal and antibacterial capabilities as well. Now we have coconut oil demonstrating powerful antioxidant potential, even powerful enough for reducing the biological stress of chemotherapy. Here are two new studies that point this out.
Autism spectrum disorders (ASD) can include what are commonly defined as impeded social interactive developments and learning disorders. ASD could be as mild as hyperactivity and attention deficit or as extreme as total developmental shutdowns at early ages, little to no language abilities, and possibly chronic epileptic seizures. The ketogenic diet is simply one that restricts carbohydrates, especially refined carbohydrates, allows moderate or adequate protein intake, and enhances healthy organic dietary fat consumption. Categorizing the different factions of ASD psychologically unrealistically ignores the physiological aspects of ASD disorders. Instead, intense bowel and intestinal tract inflammations are listed as “co-morbid symptoms” and unrelated to ASD diagnostics. Not enough attention is placed on finding the underlying metabolic disorders involved in most cases of autism, which also produce the “co-morbid” symptoms. It’s already known that the ketogenic diet has positively impacted some with intractable epilepsy. Yet anti-seizure and anti-psychotic pharmaceuticals that at best merely control seizures without curing epilepsy are more commonly prescribed than monitored dietary changes. Not only do they have side effects, they create more metabolic disorders. Over the past two decades or so, more medical research has focused on the ketogenic diet’s potential for reducing the metabolic dysfunction that some consider as the root cause of many neurological diseases that plague us today.
Since 2015 there have been a few pharmaceutical companies working on a new cholesterol-lowering drug type as a replacement for the older class of statin drugs, such as Lipitor. Lipitor was the best-selling drug of all time, but its patent expired a few years ago. The new mantra is getting LDL cholesterol levels lower than statin drugs. The drug class of these new cholesterol-lowering drugs is a PCSK9 inhibitor. Of course, this is madness for two reasons: (1) Cholesterol and fats, in general, are not the cause of heart disease; (2) cholesterol is vital for hormone production and nervous system and brain function. The fact is that cholesterol is vitally essential for good health, and lowering cholesterol artificially can and does lead to more immediate health problems, and a lower life expectancy. So why the focus for a new cholesterol-lowering drug? Once again, we follow the money.
There are several testimonials by people using virgin coconut oil (VCO) for improving scalp conditions, hair, and skin issues. But it’s doubtful that a certified dermatologist would recommend that for most skin issues. It’s more likely that an external skin condition known as atopic dermatitis (AD), which causes excess dryness, inflammation, and pruritus (itching) will be prescribed a cortecosteroid cream to apply topically. The University of Central Florida Medical School offered a paper published early in 2017 titled “Coconut oil: The future of atopic dermatitis treatment?” Overall, VCO appears to be an emerging treatment for AD due to its safety and ability to both combat the suggested pathogenesis of AD and provide clinical improvement. More extensive trials that comprehensively examine the positive and negative effects of treating AD with VCO are indicated.